Significance of interleukin-33 and its related cytokines in patients with breast cancers
Interleukin-33 (IL-33) is a recently identified cytokine, an important member of the IL-1 family. IL-33 binds to its receptor ST2 to induce type 2 cytokines and exert both pro-inflammatory and protective functions in host defense and disease. Murine breast carcinoma models suggest disruption of ST2...
Main Authors: | Jing eLiu, Jia-Xin eShen, Jia-Lin eHu, Wen-He eHuang, Guo-Jun eZhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00141/full |
Similar Items
-
The serum levels and clinical significance of interleukin-33 and soluble ST2 in patients with vitiligo
by: Li YANG, et al.
Published: (2020-12-01) -
Serum levels of Interleukin-33 and its soluble receptor ST2 in asthmatic patients
by: Ensaf A. Azazi, et al.
Published: (2014-04-01) -
Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis
by: Liya Li, et al.
Published: (2018-11-01) -
Understanding Interleukin 33 and Its Roles in Eosinophil Development
by: Paul J. Bryce, et al.
Published: (2017-05-01) -
An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice
by: D.A.C. Magro, et al.
Published: (2013-08-01)